Amblyopia Market Research Report- Global Forecast Till 2027

Amblyopia Market Information: By Type (Strabismus Amblyopia, Refractive Amblyopia), Diagnosis (Visual Acuity Tests, Photo Screening), Treatment (Eye Patches, Atropine Drops, Glasses, Video Game), End-User (Ophthalmic Clinics) – Global Forecast Till 2027

ID: MRFR/MED/2967-HCR | February 2021 | Region: Global | 108 pages

Amblyopia Market Overview:


The amblyopia market is one of the rapidly improving market structures which is projected to achieve better future results due to the rising number of cases of cataracts, macular degenerations, and other refractive errors. which leads to continuous investments being made towards the establishment and growth of the amblyopia market size and share.


The amblyopia market is expected to grow at a CAGR of around 3.80% The market is expected to reap positive results from the Asia Pacific region where the demand for amblyopia is expected to be high due to a large proportion of the geriatric population residing in these countries and the increasing number of cases of cataracts and other disorders in the countries of these regions. Moreover, the segment by end-user is expected to contribute maximum towards amblyopia market share.


Amblyopia is a kind of eye disorder in both the eyes or in one eye which causes a decrease in the vision of the eye and not complete information being transferred to the brain. Amblyopia is a form of visual incapacity among youngsters which may be caused at the time of birth since during the birth the human visual capacity is limited, and it keeps on gaining momentum as and when the person starts to grow. The amblyopia market has been one such form of market structure that has focused on the generation of medicines towards curing the disease.


The youngsters face this problem at an early age when there is a refractive error in one or both the eyes and if not cured in the initial stages may also develop adverse effects which may ultimately lead to loss of vision. The amblyopia market is set to be growing at a rapid pace due to various investments being made by the Government towards ophthalmology research and development towards finding regenerative medicines for the treatment of amblyopia.


COVID 19 Analysis:


The novel coronavirus or the Covid 19 pandemic has negatively impacted the amblyopia industry since the rising number of amblyopia cases have faced a standstill since people have now been locked in their homes and there remains no chance for anyone to move out for amblyopia treatment unless it is too necessary due to which the amblyopia companies have faced shortages in personnel, accumulated stocks, and forced shutdowns. Due to the Covid 19 effect, it has been observed that a large number of amblyopia companies are forced to lay off employees, but it is assumed that the market will soon pick up the pace and the demand would increase. It is expected that the post-lockdown period would be a great success for the market revenue since the pending amblyopia treatment surgeries would provide a sudden increase to the global market scenario. It is also analyzed that every segment would be contributing significantly towards the growth of amblyopia market value.


MARKET DYNAMICS


Drivers:


The amblyopia market has been experiencing a diversified growth in all segments and across different regions due to the rising number of cases of amblyopia especially in the young population and the proportion of the youth in the overall population stands more on a higher side which has been a major driver for the global market size.


Secondly, the growing cases of ophthalmological disorders and the rising number of cases of visual incapacities such as cataracts, macular degeneration, glaucoma, and other refractive orders have also driven the market since the need to impair such disorders require treatment surgeries and healthcare facilities that fall under the ambit of market structure.


Another major driver in the global amblyopia market has been the ever-increasing health awareness programs and missions which have motivated people all over the world towards improvement in their health stats and to also be aware of various impairment disorders or other visual incapacities which could affect them and also lead to loss of vision. Also, the improvement in health care facilities all around the world and expenditures being made by the public and private entities have facilitated the market to have vast growth.


Restraints:


The overall growth in the market has been expediently rising but certain factors hinder the growth process of the market which include large sums of money to be invested initially in setting up amblyopia treatment companies and thus it restricts various new players to enter the markets.


Another key factor that acts as a barrier towards an increase in amblyopia market share is the stringent and rigid system of rules and regulations from the Governments of different countries. Apart from this, a major challenge that has stood out is that even after the surgeries and the treatment the desired outcome of vision is not achieved and there have been instances of the disorder recurring.


Another key restraint that has been observed off late is the high cost of amblyopia which bars most of the patients who are not aptly equipped with all the financial resources and also affects amblyopia market share since it cannot cater to the diverse variety of patients of different sections of the society. The Government also tries to curb the cost of such treatment which als affects the healthcare workers negatively.


Technology Analysis:


The amblyopia market trends have been dedicated towards the use of improved technology in the treatment process since the procedure for amblyopia is based on highly scientific procedures and methods, it is usually carried on with the help of advanced tools and machines.


However, to be more specific, amblyopia procedures are based on scientific tests and screening of the individual to locate the exact point of disorder and to provide necessary treatment for it. This includes the visual acuity tests, the Buckner tests, and photo screening of the entire eye to provide a complete view of the affected area and the complexities involved in the visual system.


The technological system to be used soon in the amblyopia market involves using robotics and artificial intelligence systems to provide for the specific and timely location of any visual incapacity or a blind spot and then proceed with the treatment process and to remove any such incapacity by minimizing every threat associated with the treatment and also ensuring that amblyopia does not return after the treatment.


Study Objectives:



  • To analyze the trends that are prevalent in the global amblyopia market regions and players that will dominate the global trends and lead the market operations towards growth figures that have been predicted by the prominent leaders in the international market and key experts for the ongoing forecast period that ends in 2028.

  • To understand the scale of functioning of the global amblyopia market segments that are prevalent through their ability to meet the vibrant needs of the target audience for market products and services.

  • To draw a competitive scale amongst the global amblyopia market players and to understand the recent developments of the key market players in the recent past that promise great results to the market for the ongoing forecast period and amblyopia market trends that end in 2028. 


Segment Overview:


The amblyopia market has been segmented as follows:


By type



  • Strabismus amblyopia

  • Refractive amblyopia

  • Deprivation amblyopia,

  • Reverse amblyopia

  • Other


By diagnosis



  • Visual acuity tests

  • Photo screening

  • Bruckner test

  • Others.


By treatment



  • Eye patches

  • Atropine drops

  • Glasses

  • Video game

  • Others


By end-user



  • Hospitals & pharmacies

  • Ophthalmic clinics

  • Others.


By Region


North America



  • The U.S.

  • Canada

  • Mexico


Europe



  • Germany

  • France

  • UK

  • Italy


Asia-Pacific



  • Japan

  • China

  • Australia

  • India


LAMEA



  • Brazil

  • Saudi Arabia

  • South Africa


Regional Analysis:


The global amblyopia market has been divided into four regions where each region has been contributing significantly in terms of its capabilities and population demands. However, among the four regions, the Asia Pacific region has been accounting for the major amblyopia market share whereby the key drivers towards the growth of the amblyopia industry are developed here, and the population seems to be quite interested in the innovations in terms of new products in the market.


The major amblyopia market revenue is expected to come from countries like China, Japan, Korea, and India. The amblyopia statistics indicate that the population along with the disposable incomes of people of these countries has been increasing which has led to shifts in lifestyles and changing demands. The shift of the people towards health awareness and improvement in healthcare facilities has contributed towards the growth of the market in this region.


The European region has also been experiencing major growth with contributions coming from developed nations such as France, Germany, Denmark, Belgium, etc. since a majority of the population in this region is quite young which has increased the number of cases in this region rapidly. Also, rapid improvements in technology have led to the widespread development of the market in these countries. The North American region is also experiencing vast growth in amblyopia market shares as the countries in this region have been reaping the benefits of technology thereby maximizing the level of operations and reducing operational cost.


Competitive Landscape:


The competitive landscape in terms of the amblyopia market has been immense and nail-biting with new players easily entering the market and the existing players making huge investments in this segment.



  • Amblyopia (Holding) Pty Ltd

  •  Amblyotech, Inc

  • Good-Lite Co

  •  Vivid Vision, Inc.

  • Cooper Vision

  • Johnson & Johnson

  •  Novartis AG

  • Carl Zeiss AG

  • HOYA Corporation

  •  Krafty Eye Patches

  • Fresnel Prism and Lens Co.

  •  Hilco Vision,

  • McKesson Corporation


The key players in the market are more focused on developing future strategies and set themselves as joint ventures to increase the amblyopia market share and size.


Recent Developments:



  • Recently Luminopia, a leading therapeutic company, announced on the basis that it has gained approval from the US government to use TV shows as a prescription therapy for children with ‘lazy eye’. This would provide a boost to the amblyopia market.

  • Recently in Australia, the National Institute of Health discovered and on the basis of their study developed a screening device that can easily identify the amblyopia in a child’s eye. The device works on a process in which the screening device scans the two retinas of the child’s eyes from a particular distance and produces results regarding whether the child needs the help of an eye physician or not.


Report Overview:


The Global report helps the investors to gain meaningful information about the market and make decisions wisely. The report discusses the steps taken by the market leaders to boost the market growth and inflate market valuation for their good. The report fully summarises the ongoing market scenario in the market which would help the intended audience to seek more information about the market. The objective of the report was to fully summarise the key players in the market and their role in boosting the amblyopia market value. The report also discusses the future growth prospects and the competitive landscape in the amblyopia industry and lays down the expected growth rate of the market along with the hindrances it may face.


 



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   3.80% (2017-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Diagnosis, Treatment and End-User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Amblyoptica (Holding) Pty Ltd, Amblyotech, Inc, Good-Lite Co, Vivid Vision, Inc., Cooper Vision, Johnson & Johnson, Novartis AG., Carl Zeiss AG, HOYA Corporation, Krafty Eye Patches¸ Fresnel Prism and Lens Co., Hilco Vision, McKesson Corporation
  Key Market Opportunities

  • Presence of huge patient population
  • Rapid development in technology
  •   Key Market Drivers

  • Increasing prevalence of ophthalmological disorders
  • Increasing technological advancement


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    Amblyopia Market is projected to grow at a 3.80% CAGR between 2017-2023.

    Different end users of Amblyopia Market include ophthalmic clinics, hospitals and pharmacies, and others.

    The Americas is expected to lead the Amblyopia Market.

    Eye patches segment will lead the Amblyopia Market.

    Rising incidence of various ophthalmological disorders is adding market growth.

    [{"chapter_no"=>"1", "title"=>" Report Prologue", "enterprise_usd"=>1350, "description"=>nil}, {"chapter_no"=>"2", "title"=>"Introduction", "enterprise_usd"=>0, "description"=>"2.1 Market Definition 16\n2.2 Scope of Study 16\n2.3 Research Objective 16\n2.4 Assumptions & Limitations 16\n2.4.1 Assumptions 16\n2.4.2 Limitations 16\n"}, {"chapter_no"=>"3", "title"=>" Research Methodology ", "enterprise_usd"=>0, "description"=>"3.1.1 Primary Research Methodology 19\n3.1.2 Secondary Research Methodology 20\n3.1.3 Market Share Analysis 20\n3.1.4 Market Pricing Approach 20\n"}, {"chapter_no"=>"4", "title"=>"Market Dynamics ", "enterprise_usd"=>950, "description"=>"4.1 Introduction 23\n4.2 Drivers 24\n4.2.1 Increasing Prevalence of Ophthalmological Disorders 24\n4.2.2 Favorable Government Funding 25\n4.2.3 Product Advancements 26\n4.3 Restraints 27\n4.3.1 Lack of Awareness 27\n4.3.2 Longer Duration of Treatment 28\n4.4 Opportunity 29\n4.4.1 Entering untapped markets 29\n4.5 Mega Trend 30\n4.5.1 Technological Trends 30\n4.6 Macroeconomics 30\n"}, {"chapter_no"=>"5", "title"=>"Market Factor Analysis ", "enterprise_usd"=>950, "description"=>"5.1 Value Chain Analysis 32\n5.1.1 R&D 32\n5.1.2 Manufacturing 32\n5.1.3 Distribution & Sales 32\n5.1.4 Post-sales Monitoring 33\n5.2 Porter’s Five Forces Model 33\n5.2.1 Bargaining Power of Suppliers 33\n5.2.2 Bargaining Power of Buyers 34\n5.2.3 Threat of New Entrants 34\n5.2.4 Threat of Substitutes 34\n5.2.5 Intensity of Rivalry 34\n5.3 Investment Opportunities 34\n5.4 Pricing Analysis 34\n5.5 Demand & Supply: Gap Analysis 35\n"}, {"chapter_no"=>"6", "title"=>"Global Amblyopia Market By Type ", "enterprise_usd"=>1650, "description"=>"6.1 Introduction 37\n6.1.1 Strabismus Amblyopia 38\n6.1.2 Refractive Amblyopia 38\n6.1.3 Deprivation Amblyopia 38\n6.1.4 Reverse Amblyopia 39\n"}, {"chapter_no"=>"7", "title"=>"Global Amblyopia Market By Diagnosis ", "enterprise_usd"=>1650, "description"=>"7.1 Introduction 41\n7.1.1 Visual acuity tests 41\n7.1.2 Photo screening 41\n7.1.3 Bruckner test 41\n"}, {"chapter_no"=>"8", "title"=>"Global Amblyopia Market By Treatment ", "enterprise_usd"=>1650, "description"=>"8.1 Introduction 43\n8.1.1 Eye Patches 44\n8.1.2 Atropine Drops 44\n8.1.3 Glasses 45\n8.1.4 Video game 45\n"}, {"chapter_no"=>"9", "title"=>"Global Amblyopia Market By End User ", "enterprise_usd"=>1650, "description"=>"9.1 Introduction 47\n9.1.1 Hospitals & Pharmacies 48\n9.1.2 Ophthalmic Clinics 48\n"}, {"chapter_no"=>"10", "title"=>"Global Amblyopia Market By Region ", "enterprise_usd"=>1650, "description"=>"10.1 Americas 51\n10.1.1 North America 53\n10.1.1.1 U.S. 55\n10.1.1.2 Canada 56\n10.1.2 South America 57\n10.2 Europe 59\n10.2.1 Western Europe 61\n10.2.1.1 Germany 63\n10.2.1.2 France 64\n10.2.1.3 U.K. 65\n10.2.1.4 Italy 66\n10.2.1.5 Spain 67\n10.2.1.6 Rest of Western Europe 68\n10.2.2 Eastern Europe 69\n10.3 Asia Pacific 71\n10.3.1 Japan 73\n10.3.2 China 74\n10.3.3 India 75\n10.3.4 Australia 76\n10.3.5 Republic of Korea 77\n10.3.6 Rest of Asia Pacific 78\n10.4 Middle East & Africa 80\n10.4.1 Middle East 82\n10.4.2 Africa 84\n"}, {"chapter_no"=>"11", "title"=>"Company Landscape ", "enterprise_usd"=>1050, "description"=>"11.1 Key Player Analysis, by Product 87\n11.1.1 Patches 87\n11.1.2 Video Games 87\n11.1.3 Glasses 87\n11.2 Key Growth Strategy Analysis 87\n11.3 Recent key developments 87\n"}, {"chapter_no"=>"12", "title"=>"Company Profile ", "enterprise_usd"=>900, "description"=>"12.1 Amblyoptica (Holding) Pty Ltd 90\n12.1.1 Company Overview 90\n12.1.2 Financials 90\n12.1.3 Products 90\n12.1.4 Strategy 90\n12.1.5 Key Developments 90\n12.2 Amblyotech, Inc. 91\n12.2.1 Company Overview 91\n12.2.2 Financials 91\n12.2.3 Products 91\n12.2.4 Strategy 91\n12.2.5 Key Developments 91\n12.3 Good-Lite Co 92\n12.3.1 Company Overview 92\n12.3.2 Financials 92\n12.3.3 Products 92\n12.3.4 Strategy 92\n12.3.5 Key Developments 92\n12.4 Vivid Vision, Inc. 93\n12.4.1 Company Overview 93\n12.4.2 Financials 93\n12.4.3 Products 93\n12.4.4 Strategy 93\n12.4.5 Key Developments 93\n12.5 CooperVision 94\n12.5.1 Company Overview 94\n12.5.2 Financials 94\n12.5.3 Products 94\n12.5.4 Strategy 94\n12.5.5 Key Developments 94\n12.6 Johnson & Johnson 95\n12.6.1 Company Overview 95\n12.6.2 Financials 95\n12.6.3 Products 95\n12.6.4 Strategy 95\n12.6.5 Key Developments 95\n12.7 Novartis AG. 96\n12.7.1 Company Overview 96\n12.7.2 Financials 96\n12.7.3 Products 96\n12.7.4 Strategy 96\n12.7.5 Key Developments 96\n12.8 Carl Zeiss AG 97\n12.8.1 Company Overview 97\n12.8.2 Financials 97\n12.8.3 Products 97\n12.8.4 Strategy 97\n12.8.5 Key Developments 97\n12.9 HOYA Corporation 98\n12.9.1 Company Overview 98\n12.9.2 Financials 98\n12.9.3 Products 98\n12.9.4 Strategy 98\n12.9.5 Key Developments 98\n12.10 Krafty Eye Patches. 99\n12.10.1 Company Overview 99\n12.10.2 Financials 99\n12.10.3 Products 99\n12.10.4 Strategy 99\n12.10.5 Key Developments 99\n12.11 Fresnel Prism and Lens Co. 100\n12.11.1 Company Overview 100\n12.11.2 Financials 100\n12.11.3 Products 100\n12.11.4 Strategy 100\n12.11.5 Key Developments 100\n12.12 Hilco Vision 101\n12.12.1 Company Overview 101\n12.12.2 Financials 101\n12.12.3 Products 101\n12.12.4 Strategy 101\n12.12.5 Key Developments 101\n12.13 McKesson Corporation 102\n12.13.1 Company Overview 102\n12.13.2 Financials 102\n12.13.3 Products 102\n12.13.4 Strategy 102\n12.13.5 Key Developments 102\n"}, {"chapter_no"=>"13", "title"=>"Conclusion ", "enterprise_usd"=>750, "description"=>"13.1 Key Findings 104\n13.1.1 The CEO’s Viewpoint 104\n13.1.2 Unmet Needs 104\n13.1.3 Key Companies to Watch 104\n13.1.4 Prediction of Amblyopia Industry 104\n"}, {"chapter_no"=>"14", "title"=>"Appendix ", "enterprise_usd"=>0, "description"=>"14.1 Discussion Blue Print 106\n14.2 References 107\n"}, {"chapter_no"=>"15", "title"=>"List of Tables", "enterprise_usd"=>nil, "description"=>"TABLE 1 PRIMARY INTERVIEWS 20\nTABLE 2 GLOBAL AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 37\nTABLE 3 GLOBAL AMBLYOPIA MARKET, BY STRABISMUS AMBLYOPIA 2014-2023 (USD MILLION) 38\nTABLE 4 GLOBAL AMBLYOPIA MARKET, BY REFRACTIVE AMBLYOPIA 2014-2023 (USD MILLION) 38\nTABLE 5 GLOBAL AMBLYOPIA MARKET, BY DEPRIVATION AMBLYOPIA 2014-2023 (USD MILLION) 38\nTABLE 6 GLOBAL AMBLYOPIA MARKET, BY REVERSE AMBLYOPIA 2014-2023 (USD MILLION) 39\nTABLE 7 GLOBAL AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 44\nTABLE 8 GLOBAL AMBLYOPIA MARKET, EYE PATCHES 2014-2023 (USD MILLION) 44\nTABLE 9 GLOBAL AMBLYOPIA MARKET, ATROPINE DROPS 2014-2023 (USD MILLION) 44\nTABLE 10 GLOBAL AMBLYOPIA MARKET, GLASSES 2014-2023 (USD MILLION) 45\nTABLE 11 GLOBAL AMBLYOPIA MARKET, VIDEO GAME 2014-2023 (USD MILLION) 45\nTABLE 12 GLOBAL AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 47\nTABLE 13 GLOBAL AMBLYOPIA MARKET, HOSPITALS & PHARMACIES 2014-2023 (USD MILLION) 48\nTABLE 14 GLOBAL AMBLYOPIA MARKET, OPHTHALMIC CLINICS 2014-2023 (USD MILLION) 48\nTABLE 15 GLOBAL AMBLYOPIA MARKET, BY REGION 2014-2023 (USD MILLION) 50\nTABLE 16 AMERICAS AMBLYOPIA MARKET, BY REGION 2014-2023 (USD MILLION) 52\nTABLE 17 AMERICAS AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 52\nTABLE 18 AMERICAS AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 53\nTABLE 19 AMERICAS AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 53\nTABLE 20 NORTH AMERICA AMBLYOPIA MARKET, BY COUNTRY 2014-2023 (USD MILLION) 54\nTABLE 21 NORTH AMERICA AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 54\nTABLE 22 NORTH AMERICA AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 54\nTABLE 23 NORTH AMERICA AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 55\nTABLE 24 U.S. AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 55\nTABLE 25 U.S. AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 55\nTABLE 26 U.S. AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 56\nTABLE 27 CANADA AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 56\nTABLE 28 CANADA AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 56\nTABLE 29 CANADA AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 57\nTABLE 30 SOUTH AMERICA AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 57\nTABLE 31 SOUTH AMERICA AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 57\nTABLE 32 SOUTH AMERICA AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 58\nTABLE 33 EUROPE AMBLYOPIA MARKET, BY REGION 2014-2023 (USD MILLION) 60\nTABLE 34 EUROPE AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 60\nTABLE 35 EUROPE AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 61\nTABLE 36 EUROPE AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 61\nTABLE 37 WESTERN EUROPE AMBLYOPIA MARKET, BY COUNTRY 2014-2023 (USD MILLION) 62\nTABLE 38 WESTERN EUROPE AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 62\nTABLE 39 WESTERN EUROPE AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 62\nTABLE 40 WESTERN EUROPE AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 63\nTABLE 41 GERMANY AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 63\nTABLE 42 GERMANY AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 63\nTABLE 43 GERMANY AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 64\nTABLE 44 FRANCE AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 64\nTABLE 45 FRANCE AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 64\nTABLE 46 FRANCE AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 65\nTABLE 47 U.K. AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 65\nTABLE 48 U.K. AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 65\nTABLE 49 U.K. AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 66\nTABLE 50 ITALY AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 66\nTABLE 51 ITALY AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 66\nTABLE 52 ITALY AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 67\nTABLE 53 SPAIN AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 67\nTABLE 54 SPAIN AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 67\nTABLE 55 SPAIN AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 68\nTABLE 56 REST OF WESTERN EUROPE AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 68\nTABLE 57 REST OF WESTERN EUROPE AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 68\nTABLE 58 REST OF WESTERN EUROPE AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 69\nTABLE 59 EASTERN EUROPE AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 69\nTABLE 60 EASTERN EUROPE AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 69\nTABLE 61 EASTERN EUROPE AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 70\nTABLE 62 ASIA PACIFIC AMBLYOPIA MARKET, BY COUNTRY 2014-2023 (USD MILLION) 72\nTABLE 63 ASIA PACIFIC AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 72\nTABLE 64 ASIA PACIFIC AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 73\nTABLE 65 ASIA PACIFIC AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 73\nTABLE 66 JAPAN AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 73\nTABLE 67 JAPAN AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 74\nTABLE 68 JAPAN AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 74\nTABLE 69 CHINA AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 74\nTABLE 70 CHINA AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 75\nTABLE 71 CHINA AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 75\nTABLE 72 INDIA AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 75\nTABLE 73 INDIA AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 76\nTABLE 74 INDIA AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 76\nTABLE 75 AUSTRALIA AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 76\nTABLE 76 AUSTRALIA AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 77\nTABLE 77 AUSTRALIA AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 77\nTABLE 78 REPUBLIC OF KOREA AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 77\nTABLE 79 REPUBLIC OF KOREA AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 78\nTABLE 80 REPUBLIC OF KOREA AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 78\nTABLE 81 REST OF ASIA PACIFIC AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 78\nTABLE 82 REST OF ASIA PACIFIC AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 79\nTABLE 83 REST OF ASIA PACIFIC AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 79\nTABLE 84 MIDDLE EAST & AFRICA AMBLYOPIA MARKET, BY REGION 2014-2023 (USD MILLION) 81\nTABLE 85 MIDDLE EAST & AFRICA AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 81\nTABLE 86 MIDDLE EAST & AFRICA AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 82\nTABLE 87 MIDDLE EAST & AFRICA AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 82\nTABLE 88 MIDDLE EAST AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 82\nTABLE 89 MIDDLE EAST AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 82\nTABLE 90 MIDDLE EAST AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 84\nTABLE 91 AFRICA AMBLYOPIA MARKET, BY TYPE 2014-2023 (USD MILLION) 84\nTABLE 92 AFRICA AMBLYOPIA MARKET, BY TREATMENT 2014-2023 (USD MILLION) 84\nTABLE 93 AFRICA AMBLYOPIA MARKET, BY END USER 2014-2023 (USD MILLION) 85\n\n \n"}, {"chapter_no"=>"16", "title"=>"List of Figures", "enterprise_usd"=>nil, "description"=>"FIGURE 1 GLOBAL AMBLYOPIA MARKET 17\nFIGURE 2 RESEARCH METHODOLOGY 19\nFIGURE 3 GLOBAL AMBLYOPIA MARKET: FORECAST MODEL 21\nFIGURE 4 VALUE CHAIN - GLOBAL AMBLYOPIA MARKET 32\nFIGURE 5 PORTERS FIVE FORCES MODEL-GLOBAL AMBLYOPIA MARKET 33\nFIGURE 6 GLOBAL AMBLYOPIA MARKET, BY TYPE 2017 & 2023 (USD MILLION) 37\nFIGURE 7 GLOBAL AMBLYOPIA MARKET, BY TREATMENT 2017 & 2023 (USD MILLION) 43\nFIGURE 8 GLOBAL AMBLYOPIA MARKET, BY END USER 2017 & 2023 (USD MILLION) 47\nFIGURE 9 GLOBAL AMBLYOPIA MARKET, BY REGION 2017 & 2023 (USD MILLION) 50\nFIGURE 10 AMERICAS AMBLYOPIA MARKET, BY REGION 2017 & 2023 (USD MILLION) 52\nFIGURE 11 NORTH AMERICA AMBLYOPIA MARKET, BY COUNTRY 2017 & 2023 (USD MILLION) 53\nFIGURE 12 EUROPE AMBLYOPIA MARKET, BY REGION 2017 & 2023 (USD MILLION) 60\nFIGURE 13 WESTERN EUROPE AMBLYOPIA MARKET, BY COUNTRY 2017 & 2023 (USD MILLION) 61\nFIGURE 14 ASIA PACIFIC AMBLYOPIA MARKET, BY COUNTRY 2017 & 2023 (USD MILLION) 72\nFIGURE 15 MIDDLE EAST & AFRICA AMBLYOPIA MARKET, BY REGION 2014-2023 (USD MILLION) 81\n\n \n"}]